Recent years have witnessed great advances in applying deep learning to improve fluorescence microscopy imaging. However, enhancing the fidelity of image restoration networks and improving their ...

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise ...

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to ...

Penn Engineers have developed an open-source algorithm that combines the speed of AI with the precision of geometry to ...

FireANTS combines AI and geometry to match features in dense images faster and more accurately, with potential applications in fields like radiology. Penn Engineers have developed an open-source ...

US-DATA helps companies turn raw images, videos, audio and text into high-quality datasets for training, testing and improving AI models. NEW YORK, NY / ACCESS Newswire / May 21, 2026 / US-DATA, a ...

For Rita Wilson, body positivity isn't all sunshine and rainbows. The actress and country music singer, who was diagnosed with breast cancer in 2015, opened up about how the health battle impacted her ...

Share on Pinterest New research links a common pesticide to epigenetic changes that may relate to colorectal cancer. Image credit: Getty Images A new study suggests that environmental and lifestyle ...

EDITOR’S NOTE: This story was reported in collaboration with the Global Health Reporting Center with support from the Pulitzer Center. Vita Sara Blechner’s life changed on a Saturday afternoon. The ...

Donna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice. Subscribe ...

SAGINAW, MI -- A new exhibition, “Warhol and the Image Machine,” is opening soon at the Saginaw Art Museum & Gardens. The exhibition, which considers how Andy Warhol’s work “anticipated a world in ...

AstraZeneca isn’t letting a death in a China trial detract from the potential of its $1 billion in vivo bet, even as the candidate’s safety and efficacy profile have so far failed to separate it from ...